FindTrial
Sign In

To determine the use of radioactive skin patches on thickened skin scar

Noninvasive treatment of recalcitrant keloids with contact brachytherapy using customized Yttrium-90 skin patch: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042113
Enrollment
32
Registered
2022-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L918- Other hypertrophic disorders of the skin

Interventions

Intervention1: Yttrium-90 skin patch: All consecutive patients with recalcitrant keloids, who fulfill inclusion and exclusion criteria will be included in the study after taking informed consent befor

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients whose age is more than 18 years with recalcitrant keloid of size between 1mm to 5 cm who have undergone treatment for at least one year and last treatment should have been received before 3 months Only one or two lesions should be included in that patient

Exclusion criteria

Exclusion criteria: 1. Recalcitrant keloids present in the face. 2. All pregnant and lactating women. 3. Patients treated within 3 months

Design outcomes

Primary

MeasureTime frame
To determine the percent change in the thickness of the recalcitrant keloid every 2 months till 6 months post one day patch therapy for 3 hours.Timepoint: 2 Years—

Secondary

MeasureTime frame
To determine the symptomatic relief post therapy.Timepoint: 2 Years—

Countries

India

Contacts

Public ContactSai kishore S

JIPMER

drnandinipandit@gmail.com7598392533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026